SANTEN PHARMACEUTICAL COSANTEN PHARMACEUTICAL COSANTEN PHARMACEUTICAL CO

SANTEN PHARMACEUTICAL CO

No trades
See on Supercharts

4536 fundamentals

An in-depth look to SANTEN PHARMACEUTICAL CO operating, investing, and financing activities

4536 free cash flow for Q3 23 is 30.34 B JPY. For 2022, 4536 free cash flow was 19.87 B JPY and operating cash flow was 37.15 B JPY.

Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: JPY
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
TTM
Free cash flowYoY growth